Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies

R. Wieder,S. Novick,B. Hollis,M. Bryan,S. Chanel,KA Owusu,Danielle Camastra,Tracie Saunders,L. Pliner,J. Harrison,P. Bonate,T. Williams,S. Soignet
DOI: https://doi.org/10.1023/A:1026203418976
2003-11-01
Investigational New Drugs
Abstract:
What problem does this paper attempt to address?